C
hronic kidney disease (CKD) is defined by a reduced estimated glomerular filtration rate (GFR) or elevated urinary albumin excretion (1) . Age is the strongest predictor of CKD (2) , and CKD is reported to be present among 47% of adults 70 years or older compared with 4% of adults aged 20 to 39 years (1) . The underlying cause of CKD is often unclear (3) . The cost, discomfort, illness, and lack of perceived benefit restrict use of renal biopsies. Age-related reduction in GFR is suspected to reflect chronic histologic abnormalities on renal biopsy (4 -9) . The histologic abnormalities of CKD are global glomerulosclerosis, tubular atrophy, interstitial fibrosis, and arteriosclerosis, which together can be described as "nephrosclerosis" (10) . These histologic abnormalities are clearly associated with reduced GFR and risk for kidney failure among patients with clinically diagnosed CKD and transplant recipients (11) (12) (13) (14) . Mild nephrosclerosis is also known to occur with aging in autopsy series (15) (16) (17) (18) , but whether nephrosclerosis occurs in older adults with normal kidney function and without CKD risk factors is unknown.
Living kidney donors provide a unique opportunity to relate clinical characteristics to renal histologic findings. Because donors are selected on the basis of good health, the spectrum and severity of renal pathologic findings is limited, but this is advantageous to the study of aging in the absence of comorbid conditions. We sought to determine whether the prevalence of histologic abnormalities in the kidney increases with age in healthy adults and whether histologic findings are explained by age-related differences in kidney function or CKD risk factors.
METHODS

Study Sample
The institutional review board at Mayo Clinic, Rochester, Minnesota, approved this study. We identified living kidney donors who had core-needle biopsy of the allograft during implantation at the Mayo Clinic from 10 May 1999 to 4 February 2009. We excluded donors who declined Minnesota research authorization. All kidney donors had a thorough evaluation with a prescheduled battery of tests. We held younger adults to higher standards for health than older adults in the interpretation of specific test results and in the final assessment to receive approval or rejection as kidney donors. We generally excluded potential candidates if they had a measured GFR (iothalamate clearance) below the age-specific 5th percentile (19) or microalbuminuria (Ͼ30 mg/d). We excluded patients with diabetes mellitus and patients with glucose intolerance on the basis of age-specific thresholds (6.10 mmol/L [110 mg/ dL] or lower). Persons with hypertension were permitted to be kidney donors if blood pressure was controlled with minimal antihypertensive therapy (up to 2 agents if 1 was a thiazide diuretic). Serum lipid and uric acid were measured by protocol, but these levels had a limited role in donor approval.
Donor Characteristics
We obtained donor characteristics and test results from medical records before donation. If several test results were present, we analyzed the result closest to kidney donation. We manually reviewed medical records to obtain results of tests completed outside of the Mayo Clinic. We obtained the following kidney function tests: serum creatinine; estimated GFR, by the Modification of Diet in Renal Disease Study equation (20) ; measured GFR, by cold iothalamate clearance (19) ; and 24-hour urinary protein and albumin excretions. The serum creatinine assay was standardized (20) in October 2006, and we adjusted previous serum creatinine levels by subtracting 12.4 mol/L (0.14 mg/dL), the mean change in donor serum creatinine levels after standardization. We defined CKD by an estimated GFR less than 60 mL/min per 1.73 m 2 or urinary albumin excretion greater than 30 mg/d (21) . An ambulatory blood pressure monitor obtained systolic and diastolic blood pressure readings every 10 minutes during the day and every 20 minutes during the night over 18 hours. We analyzed mean overall blood pressure, mean active blood pressure (4 p.m. to 9 p.m.), and mean nocturnal blood pressure (12 a.m. to 5 a.m.). We defined hypertension by use of antihypertensive therapy and family history of endstage renal disease by the recipient having a biological relation to the donor. Serum lipid, glucose, and uric acid were measured from a fasting blood sample.
Histology of Kidney Tissue
Implantation renal biopsies were a routine part of the transplantation surgery, intended to provide baseline histologic findings for the recipient. After vascular and ureteral anastomoses of the allograft into the recipient by the surgeon, we obtained biopsy samples with an 18-gauge Bard Monopty biopsy gun with a 1.7-cm specimen slot (Bard Biopsy Systems, Tempe, Arizona). Renal pathologists examined formalin-fixed, paraffin-embedded sections stained with hematoxylin-eosin, periodic acid-Schiff, methenaminesilver, and Masson trichrome stains. Because we assigned biopsies to the recipient, pathologists were blinded to most donor characteristics. However, we documented donorrecipient relationships (for example, parent-child) in the recipient's chart, and in theory, the pathologist could have used these relationships to approximate donor age.
We manually abstracted biopsy reports for chronic histologic abnormalities of the kidney cortex. Reports usually provided a Banff 1997 classification score for chronic or sclerosing lesions (12) ; if not, we inferred a score from the descriptive text (none ϭ 0, mild ϭ 1, and moderate ϭ 2). Scores for interstitial fibrosis were 0 for less than 5%, 1 for 6% to 25%, and 2 for 26% to 50%. In the assessment of renal tubules for atrophy, scores were 0 for none, 1 for 25% or less, and 2 for 26% to 50%. Arteriosclerosis was characterized by how much luminal narrowing occurred for the most severely affected vessel; scores were 0 for none, 1 for 25% or less, 2 for 26% to 50%, and 3 for more than 50%. We scored the proportion of global glomerulosclerosis among glomeruli present as 0 for 0%, 1 for 25% or less, and 2 for 26% to 50%. We abstracted biopsy quality (total length of biopsy cores, number of glomeruli, and presence of medulla) from pathology reports.
Validation and Reproducibility of Kidney Tissue Histology
To address the concern that pathologists could have estimated the donor age from the donor-recipient relationship, thereby introducing diagnostic suspicion bias, 1 investigator reread biopsy slides in a blinded manner and in random order for the 19 oldest and 19 youngest donors. To evaluate the reproducibility of chronic histologic abnormalities on repeated biopsies, we identified recipients of ABO-incompatible kidneys. These recipients are at increased risk for subclinical acute rejection and thus had percutaneous repeated biopsy within 3 weeks of transplantation.
Statistical Analysis
We excluded donors with only medulla (no cortex) on renal biopsy. We described donor characteristics and chronic histologic abnormalities overall and by age group (18 to 29 years, 30 to 39 years, 40 to 49 years, 50 to 59 years, 60 to 69 years, and 70 to 77 years). We dichotomized chronic histologic abnormalities between a score of 0 versus 1 or more and used logistic regression models to assess whether these histologic abnormalities cosegregated.
Context
We know little about histologic abnormalities of the kidney (nephrosclerosis) in adults with normal renal function.
Contribution
Biopsies from 1203 living kidney donors showed that the prevalence of nephrosclerosis increased markedly with age, from less than 5% for persons aged 18 to 29 years to about 30% for persons aged 40 to 49 years and about 60% for persons aged 60 to 69 years. Differences in urinary albumin excretion, blood pressure, and glomerular filtration rate among these healthy donors did not explain the age-related increase in nephrosclerosis.
Caution
We do not yet know whether age-related histologic abnormalities of the kidney portend adverse clinical outcomes or merit any action.
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Article The Association Between Age and Nephrosclerosis Sclerosis score was defined as the sum of abnormalities among glomerulosclerosis, tubular atrophy, interstitial fibrosis, and arteriosclerosis (0 to 4). Because no universal histologic definition of "nephrosclerosis" exists (7), we defined it a priori as the lowest sclerosis score threshold with prevalence less than 5% in the 18-to 29-year age group.
We assessed reproducibility of nephrosclerosis with an agreement statistic () in the subset with repeated biopsies. Logistic regression models identified characteristics associated with nephrosclerosis. The multivariable model included age; sex; 24-hour urinary albumin excretion; measured GFR; nocturnal systolic and diastolic blood pres- 81 (14) 94 (14) 84 (13) 79 (13) 77 (12) 74 (10) (9) 118 (8) 118 (9) 118 (9) 120 (10) 124 (11) 126 (9) Ͻ0.001 Active 122 (10) 121 (9) 122 (10) 121 (10) 123 (11) 128 (12) 129 (12) Ͻ0.001 Nocturnal 108 (10) 108 (8) 107 (9) 107 (10) 108 (10) 110 (11) 112 (10) 0
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Overall 73 (7) 70 (6) 72 (6) 73 (7) 74 (7) 74 (8) BMI ϭ body mass index; BP ϭ blood pressure; CKD ϭ chronic kidney disease; ESRD ϭ end-stage renal disease; GFR ϭ glomerular filtration rate; HDL ϭ high-density lipoprotein; LDL ϭ low-density lipoprotein. * P value for Pearson correlation between the characteristic and age (continuous). † Defined as an estimated GFR Ͻ60 mL/min per 1.73 m 2 or urinary albumin excretion Ͼ30 mg/d. Physicians relied more on measured GFR than estimated GFR at the time of donor selection.
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The Association Between Age and Nephrosclerosis www.annals.orgsures; hypertension; family history of end-stage renal disease; body mass index; and total cholesterol, glucose, and uric acid levels. We considered a P value less than 0.05 statistically significant. Analyses were done by using JMP, version 8.0, and SAS, version 9.1 (SAS Institute, Cary, North Carolina).
Role of the Funding Source
The study was funded by the National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Disorders. The funding source had no role in the design and conduct of the study; collection, analysis, and interpretation of the data; preparation or review of the manuscript; or the decision to submit the manuscript for publication.
RESULTS
We identified 1221 living kidney donors with implantation biopsy of the allograft. After excluding 18 donors with biopsy samples of only medulla, we used 1203 donors in the analysis. The number of core-needle biopsy samples obtained from each donor allograft was 1 in 87% and 2 or more in 13%. The mean total length of the biopsy samples for each donor was 1.6 cm (SD, 0.4). Biopsy samples had a mean of 20 glomeruli (SD, 9) and were described as cortex in 61%, cortex and medulla in 30%, and renal parenchyma in 9%. Among the 1203 kidney donors, test results were available for 24-hour urinary albumin excretion in 94%, measured GFR in 94%, 18-hour ambulatory blood pressure in 90%, body mass index in 99%, and blood tests in at least 97%. Among these kidney donors, 93% were white. Table 1 shows other participant characteristics by age group. Measured GFR was the characteristic with the strongest correlation to age (r ϭ Ϫ0.42; P Ͻ 0.001) in this sample.
The prevalence of any global glomerulosclerosis was 48%, any tubular atrophy was 22%, interstitial fibrosis greater than 5% was 4.9%, and any arteriosclerosis was 32%; these abnormalities cosegregated. We found an association for all pairwise comparisons (P Ͻ 0.001 for each pair) that was preserved with age adjustment (P Ͻ 0.001 for each pair), except between glomerulosclerosis and arteriosclerosis after age adjustment (P ϭ 0.40). The individual and sum presence of these abnormalities (sclerosis score) increased with age, although abnormalities in the glomeruli, tubules, interstitium, and arteries generally affected less than 25% of these regions (Appendix Table, available at www.annals.org). Nephrosclerosis, defined as 2 or more different histologic abnormalities, increased with age ( Table 2) . Nephrosclerosis had a prevalence of only 2.7% (95% CI, 1.1% to 6.7%) in the youngest age group but 28% (CI, 25% to 30%) overall. The prevalence of nephrosclerosis was similar between men and women (26% vs. 29%; age-adjusted P ϭ 0.23). Exclusion of persons with hypertension only slightly decreased the prevalence of nephrosclerosis. Adjustment for sex; 24-hour urinary albumin excretion; measured GFR; nocturnal systolic and diastolic blood pressures; hypertension; family history of end-stage renal disease; body mass index; and total cholesterol, glucose, and uric acid levels did not substantially alter the trend in increasing prevalence of nephrosclerosis associated with age in crude analyses.
Characteristics associated with nephrosclerosis after adjustment for age and sex were 24-hour urinary albumin excretion (P ϭ 0.010), nocturnal systolic and diastolic blood pressures (P ϭ 0.019 and 0.002, respectively), and hypertension (P ϭ 0.020). To put these in perspective, a 32-mg increase in urinary albumin excretion, a 21-mm Hg increase in nocturnal diastolic blood pressure, a 35-mm Hg increase in nocturnal systolic blood pressure, and treated hypertension had the same association with nephrosclerosis as an 8-year increase in age. After the 18 patients with urinary albumin excretion greater than 30 mg/d were excluded, nephrosclerosis still had an age-and sex-adjusted association with nocturnal systolic and diastolic blood pressures (P ϭ 0.015 and 0.002, respectively) and hypertension (P ϭ 0.008). After adjustment for age and sex, no other characteristics (Table 1) , including CKD (P ϭ 0.75), were associated with nephrosclerosis in this sample selected on the basis of health. Glomerular filtration rate declined by 6.3 mL/min per 1.73 m 2 with each age decade (P Ͻ 0.001), but we found no evidence of effect modification by nephrosclerosis with this decline (Figure) . Adjustment for biopsy quality had no substantive effect on associations with nephrosclerosis.
According to the original pathology report, 15 of the 19 oldest donors versus 0 of the 19 youngest donors had nephrosclerosis; these proportions remained the same after the blinded reread. There were 53 donors for whom the recipient had repeated biopsy a mean 5 days after the transplant surgery. There was only modest evidence of reproducibility for nephrosclerosis ( ϭ 0.35; P ϭ 0.007). We found fewer glomeruli on the percutaneous repeated biopsy than on the intraoperative initial biopsy (mean, 15 vs. 21; P Ͻ 0.001). Article The Association Between Age and Nephrosclerosis
DISCUSSION
Among healthy adults, nephrosclerosis occurred with older age, and this was not explained by age-related differences in kidney function or CKD risk factors. The prevalence of nephrosclerosis increased linearly from 2.7% for patients aged 18 to 29 years to 73% for those aged 70 to 77 years. This increase in the prevalence of nephrosclerosis with age was preserved after adjustment for differences in kidney function and CKD risk factors. These findings reveal a subclinical age-related nephropathy that is not detected by existing clinical tests other than renal biopsy.
Traditionally, the term "nephrosclerosis" has implied that narrowing of arteries and arterioles led to ischemia, resulting in glomerulosclerosis and chronic tubulointerstitial injury (22) . In this study, we defined nephrosclerosis as a histologic pattern of sclerosis and atrophy without inferring a cause. Critical telomere shortening (23) , increased cell-cycle inhibition (24) , inflammation with accelerated apoptosis (25) , and reduction and simplification of vessels (26) may all contribute to age-related nephrosclerosis. The atrophy of nephrons that characterizes nephrosclerosis could explain the decline in kidney mass from young adults to older adults (27, 28) . The decline in GFR with aging was not explained by nephrosclerosis. Factors that govern GFR greater than needed for prevention of uremic illness are largely unknown (29) . The indexing of GFR to body surface area (1.73 m 2 ) may not account for age-related changes in physiologic demand for GFR (30) . Five percent of the kidney donors met estimated GFR and urinary albumin excretion criteria for CKD (21) before donation. These criteria for CKD may not be sufficient because they were not associated with nephrosclerosis in this healthy sample. Inaccuracy of serum creatinine-based estimated GFR (31, 32) is part of the problem, because all donors had a measured GFR greater than 60 mL/min per 1.73 m 2 . The definition of CKD has largely been defended with outcome studies (33) , but to the extent in which GFR and age are correlated, one cannot distinguish whether an outcome is linked to GFR or another age-related process (such as nephrosclerosis). The lack of association between the age-related decline in GFR and nephrosclerosis is supportive of proposed age-specific thresholds (5th percentiles) for GFR to improve kidney donor selection (32) and CKD classification (34, 35) .
The only characteristics associated with nephrosclerosis independent of age and sex in this healthy sample were urinary albumin excretion, nocturnal blood pressure, and treated hypertension. These findings support the interpretation of urinary albumin excretion as a marker of an underlying renal pathologic finding (36) . The term "hypertensive nephrosclerosis" is occasionally used to describe patients with CKD attributed to hypertension, even in the absence of a renal biopsy. However, these findings show that hypertension is associated with nephrosclerosis in adults with normal GFR and urinary albumin excretion. Nephrosclerosis may be part of the underlying pathway by which increased urinary albumin excretion, even in the normal range, predicts the development of hypertension (37).
Our study has several potential limitations. Living kidney donors are selected on the basis of good health, and they lack the spectrum and severity of renal pathologic findings present in the general population. Thus, the absence of an association in healthy adults should not be extended to the general population. The reproducibility (precision) of nephrosclerosis on renal biopsy is limited because of the small amount of tissue obtained to minimize bleeding and injury to the kidney. The implication is that, to some extent, the prevalence estimates reflect the probability of detecting nephrosclerosis with each renal biopsy in a person of a certain age. Biopsies varied with respect to the number of glomeruli, tubules, and vessels present, and this affected detection of abnormalities. However, adjustment for biopsy quality factors did not change the findings.
In conclusion, an association between age and nephrosclerosis occurs in healthy adults that is not explained by age differences in CKD risk factors, urinary albumin excretion, or GFR. Independent of age, nephrosclerosis is associated with hypertension, nocturnal blood pressure, and urinary albumin excretion but not GFR. As such, agespecific thresholds for GFR that are based on healthy adults are appropriate for living kidney donor selection and CKD screening. Studies are needed to determine whether nephrosclerosis predicts adverse outcomes. Novel tests that detect nephrosclerosis are needed to even be able to assess whether prevention or treatment strategies are warranted.
